[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Evidence-Based Dermatology: Research Commentary
December 2009

Mohs Micrographic Surgery for Basal Cell Carcinoma of the Face

Author Affiliations

Department of Dermatologic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts

Arch Dermatol. 2009;145(12):1428-1430. doi:10.1001/archdermatol.2009.315

Commentary on: Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up

Mosterd K, Krekels GA, Nieman FH, et al

Lancet Oncol. 2008;9(12):1149-1156

Question: Should patients with primary or recurrent basal cell carcinoma (BCC) be referred for surgical excision (SE) or Mohs micrographic surgery (MMS)?